MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.50
-0.85 (-6.88%)
At close: Dec 5, 2025, 4:00 PM EST
11.73
+0.23 (2.00%)
After-hours: Dec 5, 2025, 5:50 PM EST

MiNK Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for MiNK Therapeutics stock has a target of 35, which predicts a 204.35% increase from the current stock price of 11.5.

Price Target: $35 (+204.35%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$35$35$35$35
Change+204.35%+204.35%+204.35%+204.35%
* Price targets were last updated on Aug 15, 2025.

Analyst Ratings

The average analyst rating for MiNK Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy011111
Buy111110
Hold211111
Sell000000
Strong Sell000000
Total333332

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Upgrades
$35
Strong BuyUpgrades$35+204.35%Aug 15, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
$35
HoldDowngrades$35+204.35%Jul 15, 2025
William Blair
William Blair
Hold
Downgrades
n/a
HoldDowngradesn/an/aJul 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong BuyReiterates$35+204.35%Mar 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$9$35
Strong BuyMaintains$9$35+204.35%Feb 25, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.39
from -2.86
EPS Next Year
-3.97
from -3.39
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-------
Revenue Growth
-------
EPS
-6.74-11.61-8.31-6.54-2.86-3.39-3.97
EPS Growth
-------
Forward PE
-------
No. Analysts
-----44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS202520262027202820292030
High-3.22-3.79
Avg-3.39-3.97
Low-3.51-4.09

EPS Growth

EPS Growth202520262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.